Your browser doesn't support javascript.
loading
Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR.
Wolfinger, Russell D; Beedanagari, Sudheer; Boitier, Eric; Chen, Tao; Couttet, Philippe; Ellinger-Ziegelbauer, Heidrun; Guillemain, Gregory; Mariet, Claire; Mouritzen, Peter; O'Lone, Raegan; Pine, P Scott; Sharapova, Tatiana; Yan, Jian; Yuen, Peter S; Thompson, Karol L.
Affiliation
  • Wolfinger RD; SAS Institute Inc., Cary, NC, 27513, USA.
  • Beedanagari S; Alkermes Inc., Waltham, MA, 02451, USA.
  • Boitier E; Bristol Myers Squibb, New Brunswick, NJ, USA.
  • Chen T; Sanofi R&D, Disposition Safety and Animal Research, Vitry-sur-Seine, France.
  • Couttet P; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR, 72079, USA.
  • Ellinger-Ziegelbauer H; Novartis Pharma AG, CH-4057, Basel, CH, Switzerland.
  • Guillemain G; Toxicology, Bayer Pharma AG, 42096, Wuppertal, Germany.
  • Mariet C; Novartis Pharma AG, CH-4057, Basel, CH, Switzerland.
  • Mouritzen P; Sanofi R&D, Disposition Safety and Animal Research, Vitry-sur-Seine, France.
  • O'Lone R; Exiqon, DK-2950, Vedbaek, Denmark.
  • Pine PS; ILSI Health and Environmental Sciences Institute, 1156 15th NW, 2nd Floor, Washington, DC, 20005, USA. rbolone@gmail.com.
  • Sharapova T; National Institute of Standards and Technology, Stanford, CA, 94305, USA.
  • Yan J; AbbVie, Abbott Park, IL, 60064, USA.
  • Yuen PS; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR, 72079, USA.
  • Thompson KL; NIH/NIDDK, Bethesda, MD, 20892, USA.
BMC Biotechnol ; 18(1): 6, 2018 02 02.
Article in En | MEDLINE | ID: mdl-29391006
ABSTRACT

BACKGROUND:

Circulating microRNAs are undergoing exploratory use as safety biomarkers in drug development. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) is one common approach used to quantitate levels of microRNAs in samples that includes the use of a standard curve of calibrators fit to a regression model. Guidelines are needed for setting assay quantitation thresholds that are appropriate for this method and to biomarker pre-validation.

RESULTS:

In this report, we develop two workflows for determining a lower limit of quantitation (LLOQ) for RT-qPCR assays of microRNAs in exploratory studies. One workflow is based on an error threshold calculated by a logistic model of the calibration curve data. The second workflow is based on a threshold set by the sample blank, which is the no template control for RT-qPCR. The two workflows are used to set lower thresholds of reportable microRNA levels for an example dataset in which miR-208a levels in biofluids are quantitated in a cardiac injury model. LLOQ thresholds set by either workflow are effective in filtering out microRNA values with large uncertainty estimates.

CONCLUSIONS:

Two workflows for LLOQ determinations are presented in this report that provide methods that are easy to implement in investigational studies of microRNA safety biomarkers and offer choices in levels of conservatism in setting lower limits of acceptable values that facilitate interpretation of results.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Reverse Transcriptase Polymerase Chain Reaction / MicroRNAs / Limit of Detection Limits: Animals Language: En Journal: BMC Biotechnol Journal subject: BIOTECNOLOGIA Year: 2018 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Reverse Transcriptase Polymerase Chain Reaction / MicroRNAs / Limit of Detection Limits: Animals Language: En Journal: BMC Biotechnol Journal subject: BIOTECNOLOGIA Year: 2018 Type: Article Affiliation country: United States